Featured articles from the journal CHEST®, August 2023

Published monthly, the journal CHEST 新しいタブ／ウィンドウで開く^® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.

The August issue 新しいタブ／ウィンドウで開く of the CHEST journal contains 47 articles, including clinically relevant research, reviews, case series, commentary and more. Each month, the journal also offers complementary web and multimedia resources 新しいタブ／ウィンドウで開く, including visual abstracts, to expand the reach of its most interesting, timely and relevant research.

“With recommendations for mouthpiece ventilation, transition to home mechanical ventilation, salivary secretion management and airway clearance therapies, the August issue contains new clinical practice guideline, ‘Respiratory Management of Patients With Neuromuscular Weakness 新しいタブ／ウィンドウで開く,’” says Editor-in-Chief of the journal CHEST, Peter Mazzone, MD, MPH, FCCP. “Also featured in the August issue is the multisociety evidence review, ‘Effect of Race and Ethnicity on Pulmonary Function Testing Interpretation 新しいタブ／ウィンドウで開く.’”

Additional highlights from the latest issue of the journal CHEST include:

• Diffuse Lung Disease Original research, “Disparities in Antifibrotic Medication Utilization Among Veterans With Idiopathic Pulmonary Fibrosis 新しいタブ／ウィンドウで開く,” shows that, among 14,792 veterans with idiopathic pulmonary fibrosis, 17% received antifibrotics, and there were significant disparities in adoption associated with sex, race, and residence. View the visual abstract for this research. 新しいタブ／ウィンドウで開く

• Pulmonary Vascular In a retrospective observational study, “Prognostic Value of Respiratory Variation in Right Atrial Pressure in Patients With Precapillary Pulmonary Hypertension 新しいタブ／ウィンドウで開く,” lack of respiratory variation in right atrial pressure was associated with lower cardiac index. View the visual abstract for this research. 新しいタブ／ウィンドウで開く

• Sleep A large cohort study, “Polysomnographic Assessment of Sleep Disturbances in Cancer Development 新しいタブ／ウィンドウで開く,” confirms the importance of polysomnographic phenotypes and highlights the role that periodic limb movements of sleep and oxygenation desaturation may play in cancer. View the visual abstract for this research 新しいタブ／ウィンドウで開く

---

Notes for editors

To view the entire August issue of CHEST journal (volume 164, issue 2), published by Elsevier, visit journal.chestnet.org 新しいタブ／ウィンドウで開く and follow @journal_CHEST 新しいタブ／ウィンドウで開く on social media for the latest journal news.

Full text of these articles and interviews with the authors are available to credentialed journalists upon request; contact Laura DiMasi, Senior Specialist, Communications and Public Relations, American College of Chest Physicians (CHEST), at [email protected] 新しいタブ／ウィンドウで開く.

About the journal CHEST^®  

 The journal CHEST 新しいタブ／ウィンドウで開く, the official publication of the American College of Chest Physicians®, features the best in peer-reviewed, cutting-edge original research in the multidisciplinary specialties of chest medicine: pulmonary, critical care, and sleep medicine; thoracic surgery; cardiorespiratory interactions; and related disciplines. Published since 1935, it is home to the highly regarded clinical practice guidelines and consensus statements. Access the journal CHEST online at journal.chestnet.org 新しいタブ／ウィンドウで開く.

About the American College of Chest Physicians 

The American College of Chest Physicians^® (CHEST) is the global leader in the prevention, diagnosis, and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication, and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care, and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST^®, visit chestnet.org. 新しいタブ／ウィンドウで開く

エルゼビアについて

エルゼビアは情報分析を専門としたグローバル企業として、研究者や医療専門家の方々を支援し、社会にとっての利益最大化に向けて、科学や医療の進展を支えています。これは、信頼できるエビデンスによるコンテンツと高度なAI対応によるデジタル技術に基づく革新的なソリューションにより、知見の集積や重要な意思決定を支援することで実現されています。

エルゼビアは、全世界で9,700人の従業員（うち技術者2,300人以上）を抱え、140年以上にわたって、研究者、図書館員、アカデミックリーダー、資金提供者、政府、研究開発集約型企業、医師、看護師、将来の医療専門家、教育者など研究・医療分野におけるパートナーの重要な活動を支援してきました。エルゼビアが刊行する3,000誌以上の科学ジャーナルと代表的な参考書には、The Lancet 新しいタブ／ウィンドウで開く、Cell Press 新しいタブ／ウィンドウで開くおよびGray’s Anatomyなどをはじめとする、各分野を代表する主要なタイトルが含まれています。 エルゼビア・ファンデーション 新しいタブ／ウィンドウで開くとの活動を通し、私たちがサービスを提供する地域社会と連携して、開発途上国を含む世界中の医学、研究、医療分野における、インクルージョン＆ダイバーシティ（I&D）の改善に努めています。

エルゼビアは、専門家および企業向けの情報分析および意思決定ツールのグローバルプロバイダーであるRELX Group 新しいタブ／ウィンドウで開くの一事業を担っています。エルゼビアの事業内容、デジタルソリューション、コンテンツなどの詳細については、www.elsevier.comをご覧ください。